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The rapid increase of the prevalence of autism spectrum disorder (ASD) suggests that
exposure to chemicals may impact the development of ASD. Therefore, we reviewed
literature on the following chemicals, nutrient to investigate their association with ASD:
(1) smoke/tobacco, (2) alcohol, (3) air pollution, (4) pesticides, (5) endocrine-disrupting
chemicals, (6) heavy metals, (7) micronutrients, (8) fatty acid, and (9) parental obesity
as a proxy of accumulation of specific chemicals or nutritional status. Several chemical
exposures such as air pollution (e.g., particular matter 2.5), pesticides, bisphenol A,
phthalates, mercury, and nutrition deficiency such as folic acid, vitamin D, or fatty acid
may possibly be associated with an increased risk of ASD, whereas other traditional risk
factors such as smoking/tobacco, alcohol, or polychlorinated biphenyls are less likely
to be associated with ASD. Further research is needed to accumulate evidence on the
association between chemical exposure and nutrient deficiencies and ASD in various
doses and populations.
Keywords: autism spectrum disorder, air pollution, chemicals, pesticide, fatty acid, micronutrients, heavy metal,
environment
INTRODUCTION
Autism spectrum disorder (ASD) is a developmental disorder typified by impaired communication
and social skills (Grabrucker, 2012). A recent increase in cases of ASD from 4–5 of 10,000 persons
in 1966 to 100 cases of 10,000 persons currently (Fombonne, 2009) may not solely be explained
by genetic factors (Abrahams and Geschwind, 2010). Thus, it needs to be determined whether
environmental factors play a role in the onset of ASD (Grabrucker, 2012), and a recent study using
twin samples reported that around 50% of cases of ASD can be explained by environmental factors
(Hallmayer et al., 2011).
In the present mini-review, we report several relatively new studies that have evaluated the
association between ASD and environmental factors by focusing on chemical or nutritional
exposures because these are modifiable factors. These exposures included smoking/tobacco,
alcohol, air pollution, pesticides, endocrine-disrupting chemicals, heavy metals, micronutrients,
and fatty acid. Parental obesity was also included as an exposure because maternal obesity can be
an indicator of exposure to chemicals or nutrition.
SMOKE OR TOBACCO
Although not consistent, most recent population-based studies have suggested that maternal
smoking during pregnancy is not directly associated with ASD after adjusting for socioeconomic
status (Burstyn et al., 2010; Kalkbrenner et al., 2012; Lee et al., 2012; Tran et al., 2013). For example,
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Lee et al. (2012) performed a population-based nested case-
control study of 3958 cases of ASD and 38,983 controls in a
longitudinal register-based study consisting of individuals aged
4–17 years, and found that maternal smoking during 8–12
weeks of gestation was significantly associated with an increased
odds of high-functioning autism in an unadjusted model (odds
ratio [OR] = 1.22, 95% confidence interval [CI]: 1.09, 1.36);
however, this finding was no longer statistically significant after
adjusting for parental socioeconomic status. Additionally, Tran
et al. (2013) conducted a population-based nested case-control
study comprising 16,185 samples, including 4020 cases of ASD,
based on the Finnish National Birth Cohort. Maternal smoking
during all pregnancies was not associated with the offsprings’
ASD status after adjusting for confounding factors.
Considering that these studies were conducted mostly among
Caucasians, the impact of smoking on the development of ASD
may differ by race. Zhang et al. (2010) conducted a case-control
study using 190 Han children aged 3–21 years with and without
autism in China, and found that maternal second-hand smoke
exposure during pregnancy, was significantly associated with
autism (OR= 3.53, 95% CI: 1.30, 9.56), suggesting that maternal
smoking may be associated with ASD among Asians.
ALCOHOL
Few studies have evaluated the impact of maternal alcohol use
on the onset of ASD among offspring. Two population-based
nested control studies in North European countries reported that
maternal alcohol intake during pregnancy was not associated
with ASD (Daniels et al., 2008; Eliasen et al., 2010).
AIR POLLUTION
In the last decade, literature on the effect of air pollution exposure
during pregnancy on the risk of ASD has grown immensely.
Although a large study using direct person-based air sampling
is needed, the analytical models used to calculate residence-
based effects have become increasingly complex to correctly
estimate exposure during a specific time. Regardless of this
change in measuring the effect of exposures, most studies have
shown a positive association between air pollution exposure and
ASD (Suades-Gonzalez et al., 2015). Recent findings support
that exposure to particulate matter (PM) <2.5 µm in diameter
(PM2.5) during the third trimester causes the most detrimental
effect on the development of ASD (Kalkbrenner et al., 2015; Raz
et al., 2015; Talbott et al., 2015; Weisskopf et al., 2015).
One of the earlier studies that measured air pollution during
pregnancy was conducted in 2011 using the distance of one’s
residence to major roadways as its proxy. Comparing 304 cases of
ASD and 259 controls, Volk et al. (2011) reported that mothers of
children with ASD were more likely to have lived near a freeway
during their third trimester (OR 2.22, CI: 1.16, 4.42) or at the time
of delivery (OR 1.86, CI: 1.04, 4.42). This study raised another
research question: which type of air pollution has the most effect
on the onset of ASD? Evidence of the effect of ozone or nitro-
oxides on ASD has been inconclusive (Becerra et al., 2013; Gong
T. et al., 2014; Guxens et al., 2016), but maternal exposure to
small particles such as diesel PM (Windham et al., 2006; Roberts
et al., 2013), PM 2.5 (Becerra et al., 2013; Volk et al., 2013; Raz
et al., 2015; Talbott et al., 2015), and PM <10 µm in diameter
(PM10) (Volk et al., 2013; Kalkbrenner et al., 2015) has been
most consistently reported with an increased risk of ASD. Several
case-control studies have investigated the effect of individual
hazardous air pollutants (HAP) such as metals and volatile
organics on ASD (Windham et al., 2006; Kalkbrenner et al., 2010;
Roberts et al., 2013; von Ehrenstein et al., 2014) with all studies
conducted in the United States showing that cases of ASD have an
elevated exposure of HAP by 1.3–2.0 times. However, two reports
from European countries (Guxens et al., 2016) and a separate
twin study in Sweden (Gong T. et al., 2014) showed no association
of maternal exposure to air pollution and ASD.
Most studies about the effect of air pollution on ASD have
been prone to residual confounders such as a low socioeconomic
status, which is related to both worse living environments and an
increased risk of ASD (Bell and Ebisu, 2012; Shmool et al., 2014).
PESTICIDES
Evidence from previous studies has suggested a strong
relationship between pesticide exposure and ASD. Despite the
quick turnover in commercial product names, organophosphates
(OP) and organochlorines (OC) are still in use despite their
neurotoxicity (Kalkbrenner et al., 2014). The association between
ASD and pesticides has been observed across studies that
measured exposures from residential exposure to agricultural
drift (Roberts et al., 2007; Roberts and English, 2013),
administered questionnaires on the use of insecticides (Keil
et al., 2014), and assessed bio-specimens to detect metabolites
(Rauh et al., 2006; Eskenazi et al., 2007; Cheslack-Postava et al.,
2013) and numerous pesticides, including but not limited to OC
(Roberts et al., 2007; Cheslack-Postava et al., 2013; Roberts and
English, 2013; Braun et al., 2014) and OP (Rauh et al., 2006;
Eskenazi et al., 2007; Shelton et al., 2014) pesticides.
Shelton et al. (2014) compared 486 cases of ASD and 316
controls, and found an association with OP exposure and ASD,
which strengthened later in pregnancy for mothers living within
1.75 km from the agricultural use of OP during their third
trimester. They also found increased exposure to pyrethroids in
patients with ASD. Eskenazi et al. (2007) and Rauh et al. (2006)
reported that cases of ASD had higher OP metabolites during
early- tomid-pregnancy. Other case-control studies reported that
exposure to imidacloprid through the consistent use of flea/tick
pet treatment throughout pregnancy period was associated with
ASD (Kalkbrenner et al., 2014; Keil et al., 2014).
ENDOCRINE-DISRUPTING CHEMICALS
Although, polychlorinated biphenyl (PCB) and several dioxins
such as tetrachlorodibenzodioxin were banned by the Stockholm
Convention in 2001, they are still detected in humans due to their
long half-life in the environment, as well as the consumption of
predatory fish in which such chemicals tend to accumulate. Other
chemicals are still used, such as bisphenol A (BPA), in many
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canned foods, receipts, toys, and medical equipment, and some
chemicals such as polybrominated diphenyl ethers and phthalates
may have even increased body burden (Zota et al., 2008, 2014).
Studies on these chemicals are sparse with mixed findings.
Associations between ASD and PCB are inconsistent (Kim
et al., 2010; Cheslack-Postava et al., 2013; Braun et al., 2014),
and the seemingly elevated risks in a pilot study (Cheslack-
Postava et al., 2013) have been criticized for possible bias due
to lack of adjustment for birth order (Kalkbrenner et al., 2014).
Kardas et al. reported higher serum BPA concentrations in a
case-control study of 48 cases of ASD and 41 controls, but no
measurement of prenatal exposure was reported (Kardas et al.,
2016). Braun et al. (2014) and Miodovnik et al. (2011) failed to
find any association with the score of Social Responsiveness Scale
(SRS), measurement of ASD traits, and maternal BPA serum or
urine concentration and in their cohort studies; however, Braun
et al. (2009) found that mid-pregnancy BPA concentrations were
associated with an increase in externalizing problem behaviors in
early childhood.
However, studies on phthalates mostly suggest an association
between ASD and phthalates. Miodovnik et al. (2011) studied 137
children and found that higher phthalate metabolites in maternal
urine in the third trimester were associated with a lower score on
several of the SRS subscales at 7–9 years old (Miodovnik et al.,
2011). Larsson et al. (2009) followed 4779 children and reported
that those at 1–6 years old living in homes with polyvinyl chloride
flooring (a significant source of phthalates) were 2.4 times more
likely to be diagnosed with ASD (Larsson et al., 2009). Kardas
et al. (2016) also reported higher serum phthalates concentrations
in cases of ASD (Kardas et al., 2016). Braun et al. (2014) failed to
detect an association between phthalates in maternal urine and
ASD, and Phillipat et al. (Philippat et al., 2015) also failed to detect
an association between house dust levels of phthalates and ASD;
however, Phillipat et al. explained that the lack of association may
be due to fact that the measured exposure may have only poorly
reflected the actual exposure of phthalates.
HEAVY METALS
There is sufficient evidence that maternal exposure to heavy
metals such as lead, mercury, cadmium, and arsenic cause an
increase in neurodevelopmental disorders, and restrict fetal and
infant growth even at low-level exposures (De Palma et al., 2012;
Ornoy et al., 2015). However, less research has been conducted on
heavy metals in relation to ASD. Recently, Rossignol et al. (2014)
systematically reviewed literature on environmental toxicants
and summarized 40 case-control studies that compared a variety
of heavy metal concentrations (i.e., lead, mercury, arsenic,
cadmium, aluminum, fluoride, manganese, chromium, nickel,
uranium, and tin) in blood, hair, brain, teeth, or urine in children
with ASD compared to controls, as well as seven similar studies
on urinary porphyrin, which is considered to have a heavy
metal burden (Rossignol et al., 2014). The most studied metals
were mercury (29 studies) and lead (25 studies). Although the
urinary porphyrin studies collectively suggest a higher heavy
metal burden among children with ASD, a recent study by
Dickerson et al. (2015) found that among 2489 children the
prevalence of ASD was higher when mothers were living closer
to industrial facilities that released arsenic, lead, or mercury.
A meta-analysis of seven studies on the mean hair level of
mercury in a total of 343 cases of ASD and 317 controls did not
show any significant association between mercury and ASD (De
Palma et al., 2012) and neither did a recent cohort study by van
Wijngaarden et al. (2013) on 1784 children and young adults.
Some studies that assessed blood have found an association
between mercury and ASD (Ip et al., 2004; Desoto and Hitlan,
2007; Geier et al., 2010), whereas others have not (Hertz-Picciotto
et al., 2010; Stamova et al., 2011; Albizzati et al., 2012; Adams
et al., 2013; Rahbar et al., 2013). However, the lack of adjusting
for strong protective factors such as fish oil that are ingested
concomitantly in many of the studies (Karagas et al., 2012) and
the possible conflict of interest with industries (Kern et al., 2015)
may be masking existing associations, as studies on air-borne
mercury consistently report an association between mercury
exposure and ASD (Windham et al., 2006; Roberts et al., 2013).
MICRONUTRIENTS
Micronutrients are essential for neurogenesis and the
development of the neuro-network (Curtis and Patel, 2008).
Lower levels of magnesium (Strambi et al., 2006), zinc (Adams
and Vogelaar, 2005), selenium (Adams and Vogelaar, 2005),
vitamin A (Adams and Vogelaar, 2005), vitamin B complex
(Adams and Vogelaar, 2005; Pineles et al., 2010), vitamin D
(Adams and Vogelaar, 2005; Gong Z. L. et al., 2014; Kocovska
et al., 2014), vitamin E (Adams and Vogelaar, 2005), and
carnitine (Filipek et al., 2004) in blood, hair, or other tissue
among children with ASD have been reported. Further, the
association between a deficiency of micronutrients during
pregnancy, such as folic acid (Schmidt et al., 2011, 2012; Suren
et al., 2013) and vitamin D (Cannell, 2008; Grant and Soles,
2009), have been reported as a risk for offspring developing ASD.
These previous studies advanced to intervention studies to
confirm the causality or possibility of using nutrients to treat
ASD. Several studies have reported that nutritional intervention
showed a trend toward improvement in patients with ASD.
For example, a double-blind study on 20 children (age 3–8
years) with ASD who took a broad-based multi-vitamin and
mineral supplement suggested the possible benefit of improving
general behavior and receptive language, although this finding
was not significant (Adams and Holloway, 2004). Another
double-blind study reported that supplementing L-carnosine
to children (age 3–12 years) with ASD showed statistically
significant improvements in the symptoms on ASD (Chez et al.,
2002). In another study, it was also reported that oral magnesium
and vitamin B6 supplements led to improvements in social
interactions, communication, stereotyped restricted behavior,
and abnormal/delayed functioning among children (age 1–10
years) with ASD (Mousain-Bosc et al., 2006).
Several studies have reported the association between gender
and ASD in the relationship with micronutrients. For example,
a study conducted in the Faroe Islands (Kocovska et al., 2014)
noted the trend for ASD males having lower levels of vitamin
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D and 25(OH)D3. Similarly, another study suggested that the
differenteial effects of estrogen and testosterone on vitamin
D metabolism might explain the gender difference of ASD
(Cannell, 2008).
FATTY ACIDS
As neural development requires essential fatty acids, particularly
long-chain omega-3 fatty acids during critical growth periods,
and inflammation may be associated with ASD (Ornoy et al.,
2015), the fatty acid level may play an important role in the
development of ASD. Several studies have shown that both red
blood cell and plasma fatty acid composition among cases of
ASD differ from those of non-ASD people. Specifically, the levels
of omega-3 fatty acids (Vancassel et al., 2001; Bell et al., 2004;
Brigandi et al., 2015), docosahexaenoic acid (DHA) (Meguid
et al., 2008; Wiest et al., 2009; El-Ansary et al., 2011; Al-Farsi
et al., 2013; Brigandi et al., 2015), and arachidonic acid (AA)
(Meguid et al., 2008; El-Ansary et al., 2011; Brigandi et al., 2015;
Yui et al., 2016) were significantly lower in the red blood cell or
plasma of cases of ASD compared to controls, although some
studies did not support these claims (Bu et al., 2006; Bell et al.,
2010). To date, only one study has examined maternal fatty acid
intake during pregnancy is association with ASD (Lyall et al.,
2013). Women with higher intake of polyunsaturated fatty acids
(PUFA) before and during pregnancy had a reduced risk of
having a child with ASD than those with lower PUFA intake.
Analysis on specific PUFAs showed that women in the highest
quartile of intake of omega-6 fatty acids had a 34% reduction in
the risk of having a child with ASD compared with those in the
lowest quartile, with similar results for linoleic acid intake. In
concern with omega-3 fatty acids, women with very low intakes
(i.e., the lowest 5% of the distribution) of had a significantly
increased risk of having a child with ASD compared with those
in the middle 90% of the distribution.
Reports on the benefits of fatty acid supplementation in
children with ASD are inconclusive. Recently, Mankad et al.
(2015) conducted a randomized controlled 6-month trial of 1.5
g/day of omega-3 fatty acids or a placebo in 38 children aged
2–5 years with ASD, and found no evidence for the efficacy
of omega-3 fatty acids on improving core symptoms (Mankad
et al., 2015). However, Ooi et al. (2015) conducted a 12-week
open-label study of 1 g/day of omega-3 fatty acids in 41 children
aged 7–18 years with ASD, and found significant improvements
in the core symptoms and attention problems (Ooi et al., 2015).
Yui et al. (2012) conducted a randomized controlled 16-week
trial of AA and DHA supplementation or a placebo in 13
individuals aged 6–28 years with autism, and found significant
improvements in social withdrawal and communication (Yui
et al., 2012). These studies were relatively small, thus the findings
may be by coincidental so a further larger randomized controlled
trial is needed.
PARENTAL OBESITY
Maternal obesity can be associated with having offspring with
ASD due to the accumulation of the aforementioned chemicals,
or it can serve as a proxy of poor nutrition (Dodds et al.,
2011; Kawicka and Regulska-Ilow, 2013; Ornoy et al., 2015).
According to a Swedish cohort study of 333,057 participants,
which included 6420 individuals with ASD, maternal overweight
or obesity evaluated at the first antenatal visit was associated with
having an offspring with ASD (Gardner et al., 2015). However,
the association between an elevated maternal body mass index
and the risk of ASD was not clear in matched sibling analyses.
In a population-based prospective cohort study of 92,909
children (age 4–13 years), Suren et al. (2014) investigated the
association between ASD and paternal obesity recorded in the
questionnaires answered by the fathers. They found that paternal
obesity was associated with an increasing risk of ASD (adjusted
OR: 1.73, 95% CI: 1.07, 2.82), whereas maternal obesity showed
only a weak association with ASD (Suren et al., 2014).
SUMMARY AND FUTURE DIRECTIONS
In summary, several chemical exposures such as air pollution
(e.g., PM 2.5), pesticides, BPA, phthalates, mercury or lead, and
nutrition deficiencies such as folic acid, vitamin D, or fatty
acid are possibly associated with the onset of ASD, whereas
other traditional risk factors such as smoke/tobacco, alcohol,
or PCB are less likely to be associated with ASD. Apparently,
no single environmental factor can explain the development of
ASD, suggesting that upstream environmental factors such as
socioeconomic status need to be considered as risk factors for
ASD, which have not been as rigorously investigated (Fujiwara,
2014). Further, few studies have investigated the accumulative
or synergistic effect of the different chemical exposures and
nutrition deficiencies simultaneously. The impact of multiple
exposures to chemicals and nutrient deficiencies, which are
suggestive of association with ASD, need to be studied together to
assess whether effect is additive or multiplicative. Moreover, not
all children exposed to these chemicals or nutrients may have risk
of developing ASD, suggesting that some genetic polymorphism
related to ASD, such as CD38 (Higashida et al., 2012), may have
an interaction effect with these environmental exposures during
the onset of ASD, as studied in the exposure of heavy mental and
genetic polymorphism related to metabolism (Rossignol et al.,
2014). Moreover, few chemical or nutritional exposures were
investigated to elucidate the mechanism of gender difference of
ASD prevalence. These uncovered topics need to be investigated
in future research.
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